Mumbai based pharma major Lupin Limited announced that its subsidiary Lupin Pharmaceuticals Inc (Lupin) has launched its Duloxetine 40 mg delayed-release (DR) capsule, which is the first and only generic Duloxetine formulation to become available in 40 mg dosage strength.
Lupin is the only generic manufacturer to offer all Duloxetine dosage strengths - the 20 mg, 30 mg, 60 mg, and now the newest 40 mg. Lupin's generic Duloxetine 40 mg DR capsules are therefore the first and only capsule available for patients in this dosage strength.
Duloxetine (Cymbalta) strengths had annual US sales of approximately US $ 1.05 billion (Brand + Generics - IMS MAT June 2015).
Duloxetine delayed-release capsules are a prescription medication used to treat major depressive disorder, generalized anxiety disorder, diabetic peripheral neuropathic pain, chronic musculoskeletal pain.
Subscribe to PharmaTutor News Alerts by Email >>
